The global short bowel syndrome market is expected to grow at a CAGR of almost 26% during the forecast period, 2017-2021. Technavio has announced its latest market research report on the global short bowel syndrome (SBS) market, under its cardiovascular and metabolic disorders portfolio. This market analysis discusses the major drivers and key emerging trends…
Technavio, a tech-focused market research firm, has published a new report on the global ENT disorder treatment market, which is expected to grow at a CAGR of more than 2% during the forecast period 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global ENT disorder treatment market into the following key regions: the…
According to Technavio’s latest market research study, the global gastroparesis drugs market is expected to grow at a CAGR of more than 3% during the forecast period, 2017-2021. This report by Technavio provides an in-depth analysis of the global gastroparesis drugs market in terms of revenue and emerging market trends. The report also includes an…
The global thyroid gland disorder treatment market is currently valued at more than USD 2,072 and is expected to reach around USD 2,358 billion by 2021, says Technavio. Technavio has announced its latest market research report on the global thyroid gland disorder treatment market, under its cardiovascular and metabolic disorders portfolio. This market analysis discusses…
Technavio, a tech-focused market research firm, has published a new report on the global venous thromboembolism therapeutic market, which is expected to grow at a CAGR of over 6% during the calculated period 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global venous thromboembolism therapeutic market into the following important regions: the…
According to the latest market research study by Technavio, the global diabetic therapeutic market is expected to grow at a CAGR of close to 8% during the forecast period of 2017 to 2021. This market research report by Technavio provides an in-depth analysis of the global diabetic therapeutic market regarding revenue and emerging market…
Technavio market research analysts foresee positive growth for many segments of the cardiovascular and metabolic disorders industry in the next five years. In their recent findings, Technavio talks about three booming markets under the cardiovascular and metabolic disorders industry that are anticipated to generate significant revenues and grow at a consistent rate during the…
Technavio, a tech-focused market research firm, has published a new report on the global compression therapy market, which is expected to grow at a CAGR of more than 5% during the forecast period, 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global compression therapy market into the following key regions: The Americas,…
The global pharmerging market is currently valued at almost USD 420 billion and is expected to reach around USD 683 billion by 2021. Technavio has announced its latest market research report on the global pharmerging market, under its cardiovascular and metabolic disorders portfolio. This market analysis discusses the major drivers and key emerging trends…
Technavio, a tech-focused market research firm, has published a new report on the global infantile spasms therapeutics market, which is expected to grow at a CAGR of more than 2% during the forecast period 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global infantile spasms therapeutics market into the following key regions:…
